Skip to main content
. 2017 May 30;3(4):281–288. doi: 10.1093/ehjqcco/qcx012

Figure 3.

Figure 3

Cumulative events over 20 years for WOSCOPS randomized cohort divided by age decade and treatment allocation (A). Panel B is the difference plot (placebo minus pravastatin) for each age decade for cumulative events in the two treatment arms. (C) The difference plot by age decade for cumulative CHD events in groups P4 and P3 in Table 1. Groups P4 and P3 comprise men who were not included in the WOSCOPS randomized trial cohort but had the same cholesterol levels as the two treatment arms. In (B) 10-year risk estimates obtained using the QRISK-2 algorithm are provided for the average WOSCOPS trial participant for non-smokers and moderate smokers. WOSCOPS, West of Scotland Coronary Prevention Study.